This invention relates to the treatment of mGluR5 receptor mediated disorders,
which comprises administering to a person in need of treatment a compound having
the formula
##STR1##
wherein R1, R2, R3, R4 and R5
are as defined in the description, A signifies -CHCH- or -CC-;
and B signifies
##STR2##
wherein R6 to R26, X and Y are as defined herein.